Geron (GERN) Enterprise Value (2010 - 2026)
Geron's (GERN) quarterly Enterprise Value came in at $521.5 million in Q2 2026, up 1.93% year-over-year from $511.6 million in Q2 2025, and down 18.64% quarter-over-quarter from $641.0 million in Q1 2026.
Analysis
Geron (GERN) Enterprise Value (2010 - 2026) Analysis & Trends
Geron has disclosed Enterprise Value across 17 years of filings, most recently posting $521.5 million for Q2 2026.
- In Q2 2026, Enterprise Value rose 1.93% year-over-year to $521.5 million; the TTM figure through Jun 2026 stood at $521.5 million (up 1.93% YoY), while the FY2025 annual figure was $486.7 million, down 72.03% from the prior year.
- Enterprise Value came in at $521.5 million for Q2 2026 at Geron, down from $641.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $2.4 billion in Q3 2024 to a low of $346.7 million in Q1 2022.
- Average Enterprise Value over 5 years is $943.9 million, with a median of $710.3 million recorded in 2022.
- Year-over-year, Enterprise Value jumped 265.33% in 2022 and tumbled 79.46% in 2025.
- Over 5 years, Enterprise Value stood at $771.7 million in 2022, then climbed by 5.75% to $816.1 million in 2023, then jumped by 113.22% to $1.7 billion in 2024, then tumbled by 72.03% to $486.7 million in 2025, then advanced by 7.16% to $521.5 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were $521.5 million in Q2 2026, $641.0 million in Q1 2026, and $486.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 521.52 Mn |
| Mar 31, 2026 | 640.98 Mn |
| Dec 31, 2025 | 486.69 Mn |
| Sep 30, 2025 | 494.01 Mn |
| Jun 30, 2025 | 511.62 Mn |
| Mar 31, 2025 | 615.82 Mn |
| Dec 31, 2024 | 1.74 Bn |
| Sep 30, 2024 | 2.40 Bn |
| Jun 30, 2024 | 2.19 Bn |
| Mar 31, 2024 | 1.51 Bn |
| Dec 31, 2023 | 816.07 Mn |
| Sep 30, 2023 | 837.77 Mn |
| Jun 30, 2023 | 1.31 Bn |
| Mar 31, 2023 | 723.28 Mn |
| Dec 31, 2022 | 771.69 Mn |
| Sep 30, 2022 | 697.30 Mn |
| Jun 30, 2022 | 366.33 Mn |
| Mar 31, 2022 | 346.66 Mn |
| Dec 31, 2021 | 211.23 Mn |
| Sep 30, 2021 | 264.95 Mn |